Back | Next |
home / stock / nnvc / nnvc message board
Subject | By | Source | When |
---|---|---|---|
Looks like the trial in India will be | KMBJN | investorshub | 05/16/2023 2:54:43 PM |
New Quarterly Report is out. Doesn't appear to | drkazmd65 | investorshub | 05/16/2023 12:47:01 PM |
$150M shelf registration goes unnoticed. | loanranger | investorshub | 05/09/2023 1:43:36 AM |
A lot of words to say almost nothing | drkazmd65 | investorshub | 04/25/2023 12:44:14 PM |
Anil keeps trying to push that peanut: | loanranger | investorshub | 04/17/2023 6:37:10 PM |
Excellent questions Sir!But overall, this is good news, | drkazmd65 | investorshub | 04/17/2023 2:28:52 PM |
Was wondering how that would work. Nanoviricides | KMBJN | investorshub | 04/17/2023 2:05:53 PM |
NanoViricides Has Shipped Drug Products for Impending Clinical | drkazmd65 | investorshub | 04/17/2023 12:32:17 PM |
Agreed,.... | drkazmd65 | investorshub | 04/13/2023 3:42:37 PM |
Agree it's clearly a promotional paid report, but | KMBJN | investorshub | 04/13/2023 2:15:39 PM |
DISCLOSURE: Zacks SCR has received compensation from the | loanranger | investorshub | 04/12/2023 1:08:32 AM |
Interesting: On April 4, 2023, NanoViricides announced a licensing | KMBJN | investorshub | 04/11/2023 8:56:56 PM |
https://finance.yahoo.com/news/nnvc-nanoviricides-technology-ready-enter-1201006 | loanranger | investorshub | 04/11/2023 1:50:44 PM |
$NNVC would first have to successfully complete the | arvitar | investorshub | 04/10/2023 8:23:41 PM |
But the only real issue is whether the | KMBJN | investorshub | 04/10/2023 8:02:48 PM |
Good grief... | arvitar | investorshub | 04/10/2023 8:02:30 PM |
Is the market seeing through this latest sham? | loanranger | investorshub | 04/07/2023 11:35:28 PM |
I think this sums it up... | loanranger | investorshub | 04/06/2023 11:31:47 PM |
Oh, what a tangled web Diwan weaves. | KMBJN | investorshub | 04/06/2023 9:38:23 PM |
Up 11+% today, but I wonder how long | drkazmd65 | investorshub | 04/05/2023 3:58:12 PM |
News, Short Squeeze, Breakout and More Instantly...
Complete Survival of Animals Lethally Infected into Lungs with RSV Achieved Upon NV-387 Oral Treatment SHELTON, CT / ACCESSWIRE / May 14, 2024 / NanoViricides, Inc. (NYSE Amer.: NNVC ) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says that antiviral activity o...
SHELTON, CT / ACCESSWIRE / May 10, 2024 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company's President and Executive Chairman, will be attending the EF Hutton Annual Globa...
NV-387 Possesses Strong Anti-Influenza-A Virus Activity, and May Have Activity Against H5N1 Bird Flu Virus, Says NanoViricides SHELTON, CT / ACCESSWIRE / May 6, 2024 / NanoViricides, Inc. (NYSE American: NNVC ) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, says...